Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed EBT Margin for 9 consecutive years, with 6837.99% as the latest value for Q1 2026.

  • For Q1 2026, EBT Margin fell 621816.0% year-over-year to 6837.99%; the TTM value through Mar 2026 reached 353.2%, down 24001.0%, while the annual FY2025 figure was 310.61%, 32709.0% down from the prior year.
  • EBT Margin hit 6837.99% in Q1 2026 for Bicycle Therapeutics, down from 53.25% in the prior quarter.
  • Across five years, EBT Margin topped out at 3416.24% in Q4 2024 and bottomed at 6837.99% in Q1 2026.
  • Average EBT Margin over 5 years is 909.36%, with a median of 619.84% recorded in 2025.
  • Year-over-year, EBT Margin soared 440202bps in 2024 and then tumbled -621816bps in 2026.
  • Bicycle Therapeutics' EBT Margin stood at 386.1% in 2022, then plummeted by -155bps to 985.78% in 2023, then soared by 447bps to 3416.24% in 2024, then plummeted by -102bps to 53.25% in 2025, then crashed by -12741bps to 6837.99% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 6837.99%, 53.25%, and 501.92% for Q1 2026, Q4 2025, and Q3 2025 respectively.